Health Care Select Sector SPDR Fund (XLV)
| Assets | $39.58B |
| NAV | $131.46 |
| Expense Ratio | 0.10% |
| PE Ratio | 14.57 |
| Shares Out | 301.12M |
| Dividend (ttm) | $1.93 |
| Dividend Yield | 1.46% |
| Ex-Dividend Date | Jun 21, 2022 |
| 1-Year Return | -0.84% |
| Volume | 1,779,609 |
| Open | 131.93 |
| Previous Close | 131.76 |
| Day's Range | 131.77 - 132.56 |
| 52-Week Low | 118.75 |
| 52-Week High | 143.42 |
| Beta | 0.75 |
| Holdings | 66 |
| Inception Date | Dec 16, 1998 |
About XLV
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Top 10 Holdings
54.39% of assets| Name | Symbol | Weight |
|---|---|---|
| UnitedHealth Group | UNH | 10.13% |
| Johnson & Johnson | JNJ | 9.09% |
| Pfizer | PFE | 5.58% |
| AbbVie | ABBV | 4.92% |
| Eli Lilly and Company | LLY | 4.80% |
| Thermo Fisher Scientific | TMO | 4.66% |
| Merck & Co. | MRK | 4.46% |
| Abbott Laboratories | ABT | 3.86% |
| Danaher | DHR | 3.79% |
| Bristol-Myers Squibb Company | BMY | 3.10% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 21, 2022 | $0.50422 | Jun 24, 2022 |
| Mar 21, 2022 | $0.42636 | Mar 24, 2022 |
| Dec 20, 2021 | $0.52752 | Dec 23, 2021 |
| Sep 20, 2021 | $0.467 | Sep 23, 2021 |
| Jun 21, 2021 | $0.48083 | Jun 24, 2021 |
| Mar 22, 2021 | $0.39747 | Mar 25, 2021 |
News
5 Sector ETFs That Show Promise After July Jobs Data
The U.S. economy added 528,000 jobs in July of 2022, breezing past market forecasts of 250,000 and above an upwardly revised 398,000 in June.
Healthcare ETFs in Focus Ahead of Q2 Earnings
The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfolio.
JNJ Beats on Q2 Earnings, Cuts View: ETFs in Focus
Johnson & Johnson continued its long streak of earnings beat. It outpaced revenue estimates as well but cut its full-year guidance on a strong dollar.
Why the Chartmaster says health care strength continues
Carter Worth of Worth Charting looks at what's next for health care stocks. With CNBC's Joe Kernen and the Fast Money traders, Tim Seymour, Jeff Mills, Bonawyn Eison and Steve Grasso.
We think there's room to run in health care, says Citi's Kristen Bitterly
Kristen Bitterly, Citi Global Wealth, joins 'Closing Bell: Overtime' to discuss why she believes there's more room to run in health care stocks.
5 Sector ETFs That Show Promise After June Jobs Data
The U.S. economy added 372,000 jobs in June of 2022, breezing past market forecasts of 268,000.
Healthcare Sector ETFs Are at the Mercy of Expiring Government Subsidies
With pandemic-era subsidies beginning to expire, healthcare could become out of reach for many Americans, potentially dragging down the health sector and related exchange traded funds. Year-to-date, the...
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
Sector ETF report for XLV
Pharma market investments: How ETFs help you dabble in the sector at a modest price
Some health care sector ETFs have exposure to companies like Johnson & Johnson, Pfizer, UnitedHealth
Defensive stocks will have the leadership position, says Ritholtz's Josh Brown
Josh Brown, Ritholtz Wealth Management CEO, joins 'Closing Bell: Overtime' to discuss navigating volatile markets.
Final Trades: Coca-Cola, Health Care, AMD & more
The "Halftime Report" traders give their top picks to watch for the second half.
All-time highs for pharma stocks: Names to trade now
Big pharma surges, and here are the names to trade. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Dan Nathan, Courtney Garcia and Karen Finerman.
Health care seems to be the perfect sector for this market, says Joe Terranova
Virtus Investment Partners' Joe Terranova explains why he likes the health care sector. With CNBC's Frank Holland and the 'Halftime Report' investment committee, Steve Weiss, Jon Najarian and Jenny Harr...
Final Trades: CVS, Amazon, Microsoft & more
The "Halftime Report" traders give their top picks to watch for the second half.
Yield Curve Inverts: 4 Value Sector ETFs to Play
The yield on the 3-year Treasury yield was higher than the 10-year U.S. treasury yield. As the yield curve inverted, play these sector ETFs.
Biggest U.S. Rate Hike Since 1994 in June: 4 ETFs to Win
In line with the market expectations, the Federal Reserve increased its benchmark interest rate by 75 bps yesterday.
Buy the Dip With These Top-Ranked ETFs
The S&P 500 entered into a bear market. Buy the dip with these ETFs.
5 Top-Ranked Safe ETF Plays for Those Fearing Market Turmoil
Against the current backdrop, we highlight some top-ranked ETFs that can be relatively safer bets either backed by their nature or favorable external factors.